http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109897824-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d84aa8c4818bda002eded1de6d318389 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea61cc86ed97c5efb9f1af04f11e2e7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033371d32d74f2f635eae9f87882a697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4dea9d5a01642f18a2ecf2f103ea85 |
| publicationDate | 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109897824-A |
| titleOfInvention | Application using TIPE2 gene as the tumour MDSC of target spot in the drug of preparation prevention or treatment tumour |
| abstract | This application discloses using TIPE2 gene as the tumour MDSC of target spot preparation prevent or the drug for the treatment of tumour in application, wherein using TIPE2 gene be target spot include using gene knockout, clpp gene subtracts or the expression of chemicals reduction TIPE2 gene.In the application of the application, the tumour MDSC of TIPE2 gene delection, on the one hand, can prevent and tumour is inhibited to occur and grow, further, it is possible to inhibit the speed of growth of existing tumour；On the other hand, antitumor immune response can be enhanced；It can be used for preparing the new targeted drug of tumor prevention or treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023092740-A1 |
| priorityDate | 2017-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.